Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed Jun 16, 2016
Insider Transaction Report
Form 4
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2016-06-15$1.88/sh+204,900$384,188→ 263,658 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-06-15−204,900→ 0 totalExercise: $1.88Exp: 2016-09-12→ Common Stock (204,900 underlying)
Holdings
- 390,792(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This option is fully vested and exercisable.